{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:20:17Z","timestamp":1787563217098,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijo.ijo_120_18","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T02:01:10Z","timestamp":1529978470000},"page":"1006","source":"Crossref","is-referenced-by-count":2,"title":["A case of human leukocyte antigen B-27-associated ocular hypotony successfully treated with golimumab"],"prefix":"10.4103","volume":"66","author":[{"given":"ParthopratimDutta","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Lakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Yamuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnindyaKishore","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanath","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.234957-1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09273940802023794","article-title":"Hypotony maculopathy in a patient with HLA-B27-associated uveitis","author":"Roe","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.234957-2","first-page":"23","article-title":"Severe HLA B27-associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion","author":"Van","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.234957-3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5414\/CP202171","article-title":"Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults","author":"Borr\u00e1s-Blasco","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.234957-4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2016.03.002","article-title":"Golimumab in refractory uveitis related to spondyloarthritis.Multicenter study of 15 patients","author":"Calvo-R\u00edo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.4103\/0301-4738.234957-5","first-page":"717598","article-title":"Golimumab as rescue therapy for refractory immune-mediated uveitis: A three-center experience","author":"Cordero-Coma","year":"2014","journal-title":"Mediators Inflamm"},{"key":"key-10.4103\/0301-4738.234957-6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.844265","article-title":"Long-term treatment with golimumab for severe uveitis","author":"Miserocchi","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.234957-7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10792-016-0239-y","article-title":"Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis","author":"Yazgan","year":"2017","journal-title":"Int Ophthalmol"},{"key":"key-10.4103\/0301-4738.234957-8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ceo.12207","article-title":"Treatment of seronegative spondyloarthropathy-associated uveitis with golimumab: Retrospective case series","author":"Faez","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.234957-9","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.24638","article-title":"Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis","author":"Emery","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0301-4738.234957-10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12348-012-0081-y","article-title":"Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis","author":"William","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"key-10.4103\/0301-4738.234957-11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/09273948.2012.741744","article-title":"Beh\u00e7et disease-associated uveitis successfully treated with golimumab","author":"Mesquida","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.234957-12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/1756-185X.12927","article-title":"Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study","author":"Pal","year":"2016","journal-title":"Int J Rheum Dis"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:13Z","timestamp":1786714393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_120_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"alternative-id":["234957"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_120_18","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}